GSWM
CLX icon

Golden State Wealth Management’s Clorox CLX Stock Holding History

Golden State Wealth Management’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.7K Buy
489
+34
+7% +$3.26K ﹤0.01% 739
2026
Q1 		$47.2K Buy
455
+1
+0.2% +$113 0.01% 700
2025
Q4 		$45.9K Buy
454
+100
+28% +$10.9K ﹤0.01% 712
2025
Q3 		$43.7K Sell
354
-101
-22% -$12.5K ﹤0.01% 709
2025
Q2 		$54.7K Hold
455
– – 0.01% 621
2025
Q1 		$67K Sell
455
-41
-8% -$6.26K 0.01% 530
2024
Q4 		$80.7K Buy
+496
New +$81.1K 0.01% 470
2022
Q1 		$552K Sell
3,971
-439
-10% -$67.3K 0.11% 165
2021
Q4 		$769K Buy
4,410
+722
+20% +$120K 0.13% 160
2021
Q3 		$611K Buy
3,688
+165
+5% +$28.4K 0.13% 143
2021
Q2 		$634K Buy
+3,523
New +$643K 0.14% 140
2020
Q2 		– Sell
-310
Closed -$54K – 307
2020
Q1 		$54K Buy
+310
New +$51.2K 0.02% 349
2019
Q4 		– Sell
-1,453
Closed -$221K – 200
2019
Q3 		$221K Buy
1,453
+192
+15% +$30.4K 0.07% 189
2019
Q2 		$193K Buy
1,261
+431
+52% +$65.8K 0.06% 229
2019
Q1 		$133K Buy
+830
New +$129K 0.04% 282

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Golden State Wealth Management's CLX Position: Q2 2026 in Review

Golden State Wealth Management increased its Clorox (CLX) stake by 7.5% in Q2 2026, buying an estimated $3.26K and bringing the position to 489 shares worth $46.7K. The position accounts for ﹤0.01% of the portfolio, ranked #739.

Golden State Wealth Management first reported a position in CLX in Q1 2019 and has held it in 15 quarters since. The position peaked at $769K in Q4 2021. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Golden State Wealth Management held 489 shares of Clorox worth $46.7K as of Q2 2026.
  • Golden State Wealth Management bought 34 Clorox shares in Q2 2026, an estimated $3.26K.
  • Clorox made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #739 holding.
  • Golden State Wealth Management first reported a position in Clorox in Q1 2019 and has held it in 15 quarters since.
  • Golden State Wealth Management's Clorox position peaked at $769K in Q4 2021.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.